Strengthening Mental Health Care in Chronic Care Patients With Hypertension. A Cluster Randomised Control Trial

April 16, 2019 updated by: Inge Petersen, University of KwaZulu
A pragmatic cluster randomized controlled trial (RCT) in 20 public sector primary care clinics in the Dr Kenneth Kaunda district of the North West Province of South Africa to assess mental health and health outcomes for depressed adults receiving hypertensive treatment by measuring the real-world effectiveness of a facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression. The control condition is enhanced usual primary health care where non-physician clinicians have been equipped with the basic skills to identify stress and depression/anxiety but with limited access to doctors authorized to prescribe antidepressant medication, and with no specific psychosocial interventions.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Cardiovascular disease (hypertension and stroke) is the leading cause of mortality in the world and the second leading cause of death in Africa. Estimates by the WHO using disability adjusted life years (DALYs) suggest that NCDs were responsible for 28% of the total burden of disease in South Africa in 2004, with heart disease, diabetes and stroke together being responsible for the second most important cause of death in adult South Africans. In the investigators 2014 survey of 3 primary health care facilities in the North West Province where the Department of Health is piloting Integrated Chronic Disease Management the investigators found that of the 1 250 chronic care patients surveyed, 51% reported having hypertension. Spurring the rising burden of NCDs are mental disorders. One in 6 adults experience a common mental disorder (depression, anxiety disorders and substance use disorders) within a 12 month period (Herman et al., 2009), one in four receive treatment of any kind (Seedat et al., 2009). Depression co-exists with NCDs having a mutually reinforcing relationship compromising both prevention and treatment through exacerbating modifiable risk factors and compromising adherence and self-care respectively. Objectives: The investigators propose to strengthen the Primary Care 101 guidelines. This is a set of clinical guidelines and decision support for nurses developed for the identification and management of multiple chronic diseases.

Study Type

Interventional

Enrollment (Actual)

1052

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North West Province
      • Dr Kenneth Kaunda District, North West Province, South Africa, 2577
        • Primary Health Care Facilities

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Clinics

  • Twenty (20) largest clinics providing chronic care Patients
  • Receiving hypertensive treatment at time of enrolment
  • Depressive symptoms as indicated by total score of 9 or more on PHQ-9
  • Planning to reside in area for the next year
  • Capable of actively engaging in interviewer-administered questionnaire at time of recruitment, 6 months and 12 months later
  • Written consent to participate in the study

Exclusion Criteria:

Clinics

  • Clinics that do not provide Integrated Chronic Disease Management
  • Small (<10 000 attendances/ year)
  • Mobile or satellite
  • Participated in piloting of intervention & data collection. Patients
  • Inability to meet the above inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
PC101 Enhanced usual primary health care where non-physician clinicians have been equipped with the basic skills to identify stress and depression/anxiety but with limited access to doctors authorized to prescribe antidepressant medication, and with no specific psychosocial interventions.
Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
Experimental: Intervention
PC101 + Mental Health Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.
Facility-based stepped care intervention combining stress and depression case detection and management by non-physician clinicians and referral pathways for anti-depressant medication and/or group/individual counselling delivered by lay-health workers for patients with depression.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: 6 Months
50 % reduction in PHQ-9 score
6 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression
Time Frame: 12 months
50 % reduction in the PHQ-9 score
12 months
Depression
Time Frame: 12 months
Remission defined as score of <5 on PHQ9
12 months
Depression
Time Frame: 6 months; 12 months
Mean PHQ9 scores
6 months; 12 months
Blood pressure
Time Frame: 6 months and 12 months
Difference in means
6 months and 12 months
Disability
Time Frame: 12 Months
Mean score using the Manual for WHO Disability Schedule WHODAS 2.0 schedule
12 Months
Stress
Time Frame: 12 Months
Mean score using Perceived Stress Scale
12 Months
Antidepressant treatment
Time Frame: 12 months
Proportion with antidepressant treatment initiated or intensified
12 months
Counselling
Time Frame: 12 months
Proportion receiving counselling by clinic-based counsellor
12 months
Referral to specialist mental health worker/service
Time Frame: 12 months
Proportion referred
12 months
Retention in care
Time Frame: 12 months
Proportion in care
12 months
Cardiovascular risk factors
Time Frame: 12 months
Difference in means
12 months
Diagnosis of other comorbid illnesses
Time Frame: 12 months
Proportion diagnosed
12 months
Quality of chronic illness care received
Time Frame: 12 months
Mean Patient Assessment of Care for Chronic Conditions (PACIC) score
12 months
Healthcare utilization
Time Frame: 12 months
Incidence rate ratio using linkage with hospitalisation databases
12 months
Productivity and economic outcomes
Time Frame: 12 months
Productivity and economic outcomes
12 months
All cause mortality
Time Frame: 12 months
Proportion died
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Graham Thornicroft, PhD, King's College London
  • Principal Investigator: Inge Petersen, PhD, University of KwaZulu
  • Principal Investigator: Lara R Fairall, PhD, University of Cape Town

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2015

Primary Completion (Actual)

October 31, 2016

Study Completion (Actual)

July 31, 2017

Study Registration Dates

First Submitted

April 10, 2015

First Submitted That Met QC Criteria

April 22, 2015

First Posted (Estimate)

April 23, 2015

Study Record Updates

Last Update Posted (Actual)

April 17, 2019

Last Update Submitted That Met QC Criteria

April 16, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HRPC10

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on PC101+Mental Health

Subscribe